共 50 条
- [41] 2'chloroxyadenosine (Cda) treatment in lupus nephritis. [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1358 - 1358
- [43] Urinary TWEAK is a novel biomarker for lupus nephritis. [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S456 - S456
- [45] The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis [J]. RHEUMATOLOGY, 2023,
- [46] Clinical efficacy of cyclosporin A neoral in the treatment of paediatric lupus nephritis with heavy proteinuria [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (02): : 217 - 221
- [48] The safety and efficacy of MMF in lupus nephritis: a pilot study [J]. LUPUS, 2001, 10 (09) : 606 - 611
- [49] Efficacy and safety of rituximab biosimilar in refractory lupus [J]. LUPUS SCIENCE & MEDICINE, 2020, 7 (01):